Dr. David Rubinow is a Distinguished Professor of Psychiatry and Chair Emeritus at the University of North Carolina-Chapel Hill School of Medicine. Renowned Key Opinion Leader in Women’s Hormonal Mood Disorders in North America. Founded, UNC Chapel Hill, Mood Disorder Program. played a pivotal role in the development of Zulresso, the first FDA and only FDA approved medication for postpartum depression.